Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
2.280
+0.100 (4.59%)
At close: Oct 31, 2025, 4:00 PM EDT
2.260
-0.020 (-0.88%)
After-hours: Oct 31, 2025, 7:12 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $63.67 million as of October 31, 2025. Its market cap has decreased by -76.94% in one year.
Market Cap
63.67M
Enterprise Value
26.31M
1-Year Change
-76.94%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $63.67M, a decrease of -48.13%. That is a compound annual growth rate of -10.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 60.87M | -81.02% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.51B |
| Johnson & Johnson | 448.03B |
| AbbVie | 399.72B |
| UnitedHealth Group | 325.74B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 218.24B |